Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients
- 1 October 1992
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 164 (4) , 323-326
- https://doi.org/10.1016/s0002-9610(05)80897-9
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Amplification of c-erbB-2 and Aggressive Human Breast Tumors?Science, 1988
- Tumor promoter and epidermal growth factor stimulate phosphorylation of the c-erbB-2 gene product in MKN-7 human adenocarcinoma cells.Molecular and Cellular Biology, 1988
- Light and electron microscopical demonstration of c-erbB-2 gene product-like immunoreactivity in human malignant tumorsVirchows Archiv B Cell Pathology Including Molecular Pathology, 1987
- OVEREXPRESSION OF THE c-erbB-2 ONCOPROTEIN IN HUMAN BREAST CARCINOMAS: IMMUNOHISTOLOGICAL ASSESSMENT CORRELATES WITH GENE AMPLIFICATIONThe Lancet, 1987
- A Mr=190,000 glycoprotein phosphorylated on tyrosine residues in epidermal growth factor stimulated KB cells is the product of the C-erbB-2 geneBiochemical and Biophysical Research Communications, 1987
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- The Product of the Human c- erb B-2 Gene: a 185-Kilodalton Glycoprotein with Tyrosine Kinase ActivityScience, 1986
- AMPLIFICATION OF c-erbB-2 ONCOGENE IN HUMAN ADENOCARCINOMAS IN VIVOThe Lancet, 1986
- Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptorNature, 1986
- The neu Gene: an erb B-Homologous Gene Distinct from and Unlinked to the Gene Encoding the EGF ReceptorScience, 1985